I think when drug costs are high, then employers have to pay more for the benefit plans they offer to their employees. There's no question about that. That's why we're really focused on trying to bring drug costs down in Canada.
We have a number of initiatives under way. I mentioned participation in the PMPRB, but also we're trying to sit down as the private insurers at the table with the pan-Canadian Pharmaceutical Alliance and negotiate as a bloc to try to bring those costs down. That, we think, will have a really important impact on drug costs in Canada.